Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component-Reference-Cited by-同舟云学术

Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component

Published:2014-04-04 Issue:4 Volume:9 Page:e93903
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cox M. Christina,Di Napoli Arianna,Scarpino Stefania,Salerno Gerardo,Tatarelli Caterina,Talerico Caterina,Lombardi Mariangela,Monarca Bruno,Amadori Sergio,Ruco Luigi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications;E Campo;Blood,2011

2. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma;K Fu;J Clin Oncol,2008

3. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia;LH Sehn;J ClinOncol,2005

4. A predictive model for aggressive non-Hodgkin's lymphoma The International Non-Hodgkin's Lymphoma Prognostic Factors Project;N Engl J Med,1993

5. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;AA Alizadeh;Nature 3,2000

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrathecal IgM synthesis as a diagnostic marker in patients with suspected CNS lymphoma;Journal of Neurochemistry;2024-02-08

2. Prognostic significance of serum monoclonal proteins based on immunofixation electrophoresis in B-cell non-Hodgkin lymphoma;Annals of Hematology;2023-12-20

3. Diffuse large B-cell lymphoma with continuously elevated immunoglobulin M following treatment: a case report with pathologic, immunophenotypic, and molecular analyses;Frontiers in Genetics;2023-11-06

4. Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting;Frontiers in Immunology;2023-09-28

5. Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review;Cancers;2023-09-06